These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 16797421
1. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Pozzi S, Lisini D, Podestà M, Bernardo ME, Sessarego N, Piaggio G, Cometa A, Giorgiani G, Mina T, Buldini B, Maccario R, Frassoni F, Locatelli F. Exp Hematol; 2006 Jul; 34(7):934-42. PubMed ID: 16797421 [Abstract] [Full Text] [Related]
2. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY. Cytotherapy; 2007 Jul; 9(4):338-47. PubMed ID: 17573609 [Abstract] [Full Text] [Related]
3. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Rieger K, Marinets O, Fietz T, Körper S, Sommer D, Mücke C, Reufi B, Blau WI, Thiel E, Knauf WU. Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839 [Abstract] [Full Text] [Related]
4. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Rico MA, Bautista G, Krsnik I, Forés R, Ojeda E, Sanjuán I, García-Marco JA, Navarro B, Gil S, Sánchez R, Panadero N, Gutiérrez Y, García-Berciano M, Pérez N, Millán I, Cabrera R, Fernández MN. Cytotherapy; 2009 May; 11(3):278-88. PubMed ID: 19308773 [Abstract] [Full Text] [Related]
5. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Jones EA, English A, Kinsey SE, Straszynski L, Emery P, Ponchel F, McGonagle D. Cytometry B Clin Cytom; 2006 Nov 15; 70(6):391-9. PubMed ID: 16977637 [Abstract] [Full Text] [Related]
6. Could cord blood be a source of mesenchymal stromal cells for clinical use? Perdikogianni C, Dimitriou H, Stiakaki E, Martimianaki G, Kalmanti M. Cytotherapy; 2008 Nov 15; 10(5):452-9. PubMed ID: 18821358 [Abstract] [Full Text] [Related]
7. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice. Hiwase SD, Dyson PG, To LB, Lewis ID. Stem Cells; 2009 Sep 15; 27(9):2293-300. PubMed ID: 19544531 [Abstract] [Full Text] [Related]
8. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C. Transplantation; 2009 Jan 27; 87(2):217-21. PubMed ID: 19155975 [Abstract] [Full Text] [Related]
9. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, Grignani P, Previderè C, Di Cesare-Merlone A, Amendola G, Bergami E, Mastronuzzi A, Maccario R, Locatelli F. Haematologica; 2008 Dec 27; 93(12):1859-67. PubMed ID: 18945748 [Abstract] [Full Text] [Related]
10. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation. Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S. Exp Hematol; 2008 Oct 27; 36(10):1370-6. PubMed ID: 18619727 [Abstract] [Full Text] [Related]
11. Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates. Masuda S, Ageyama N, Shibata H, Obara Y, Ikeda T, Takeuchi K, Ueda Y, Ozawa K, Hanazono Y. Exp Hematol; 2009 Oct 27; 37(10):1250-1257.e1. PubMed ID: 19638293 [Abstract] [Full Text] [Related]
12. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Haack-Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J. Scand J Clin Lab Invest; 2008 Oct 27; 68(3):192-203. PubMed ID: 17852829 [Abstract] [Full Text] [Related]
13. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation. Lee JJ, Nam CE, Kook H, Maciejewski JP, Kim YK, Chung IJ, Park KS, Lee IK, Hwang TJ, Kim HJ. Bone Marrow Transplant; 2003 Nov 27; 32(9):947-52. PubMed ID: 14561997 [Abstract] [Full Text] [Related]
14. [Umbilical cord blood as a source of stem cells]. Bojanić I, Golubić Cepulić B. Acta Med Croatica; 2006 Jun 27; 60(3):215-25. PubMed ID: 16933834 [Abstract] [Full Text] [Related]
18. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R. Blood Cells Mol Dis; 2008 Jun 27; 40(1):25-32. PubMed ID: 17869550 [Abstract] [Full Text] [Related]
19. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system. Gonçalves R, Lobato da Silva C, Cabral JM, Zanjani ED, Almeida-Porada G. Exp Hematol; 2006 Oct 27; 34(10):1353-9. PubMed ID: 16982328 [Abstract] [Full Text] [Related]
20. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Smiler D, Soltan M, Albitar M. Implant Dent; 2008 Sep 27; 17(3):236-47. PubMed ID: 18784524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]